ChinaBio® Partnering Forum 2026: Where partnerships and investment define the next era of biotech
This year’s agenda will explore how capital, strategy, and cross-border collaboration are reshaping China’s role in the global life sciences. Sessions will highlight the partnerships, deal models, and market dynamics driving innovation and investment, providing forward-looking perspectives for companies eager to expand, align, and thrive in a rapidly evolving landscape.
Full agenda details will be announced soon - check back for updates!
Panel sessions
ChinaBio® Partnering Forum 2025: Shaping the Future of Global Biotech
Join leading investors, big pharma, biotech innovators, and government leaders as they explore the most critical topics shaping the biotech landscape today. The agenda features sessions that dive into cutting-edge technologies, investment strategies, and the evolving role of China in the global ecosystem.
The Future of Biotech
Discover how global collaboration and China's leadership are driving innovation in biotech, transforming the industry with groundbreaking research and commercialization efforts.
AI and Big Data in Drug Discovery
Learn how AI is revolutionizing drug discovery, accelerating R&D timelines, and enabling new opportunities for personalized medicine.
Sustainability in Biotech
Explore how eco-friendly innovations are becoming a competitive advantage, from green drug manufacturing to biotech-driven sustainability solutions.
Panel sessions
AI/IoT in Healthcare
Examine how digital health technologies like wearables and telemedicine are being integrated into biotech to enhance patient outcomes and reshape healthcare delivery.
Precision Medicine in China
Gain insights into the rise of precision medicine in China, driven by advances in genomics, data analytics, and personalized treatments.
Investment Strategies
Navigate the global investment downturn and uncover the best opportunities in biotech, including new markets and emerging companies.
Regulatory Insights
Understand the impact of China’s healthcare reforms and the USA BIOSECURE Act on biotech development and cross-border partnerships, and explore how policy changes are influencing market strategies.
Pharma 4.0
Discover how digital technologies are transforming pharmaceutical production, improving quality control, and enhancing compliance in the next generation of pharma manufacturing.